5 min read

EverHint Signal — Momentum Swing: Mid Cap Focus — December 16, 2025

17 mid-cap momentum breakouts surfaced today. ENVA led with 98.1 quality score. ROIV saw -$172.8M insider selling. Most sit at 52-week highs. Earnings begin in 37-73 days.

What This Signal Is (Quick)

The Mid Cap Focus scanner targets momentum breakouts in the market's growth sweet spot: companies valued between $2 billion and $20 billion. This is where you find:

  • Established operations with proven business models
  • Room to grow without mega-cap constraints
  • Institutional attention with strong liquidity
  • Balanced risk/reward between small-cap volatility and large-cap stability

The scanner looks for stocks showing strong momentum near 52-week highs, accompanied by volume surges that confirm institutional buying. This is not a value play—it's a momentum continuation strategy designed for swing traders with a 1-4 week holding period.

Think of it as scanning for "hot hands" in the mid-cap universe—stocks that institutions are actively accumulating as they break to new highs or consolidate near resistance.

This is an experimental scanner designed for educational use and back-testing.


How We Ranked Today (Reader Version)

Today's signals are ranked by composite quality score (0-100 scale), which weighs momentum strength, relative performance, and technical setup quality. Higher scores indicate stronger setups. We overlay three contextual data points:

  1. Insider Net Flow (90 days): Open-market purchases minus sales. Heavy insider selling during breakouts can signal caution—insiders may be using momentum to exit positions.
  2. Days to Earnings: Proximity to the next earnings report. Breakouts near earnings can signal pre-positioning or create volatility risk.
  3. % of 52-Week High: How close the stock is trading to its 52-week peak. Stocks at 100% are making new highs.

These signals are for educational use and back-testing. They highlight momentum continuation setups, not fundamental analysis. Always check the broader market context before trading.


🎯 Mid Cap Focus Breakout Signals (17 Total)

Rank Ticker Company Sector Last ($) Vol Thrust % of 52W High Score Mkt Cap Insider Net (USD) Days → Earnings
1 ENVA Enova International, Inc. Financial Services 158.34 1.72x 97.4 98.1 $3.9B -$5.9M 49
2 HUBG Hub Group, Inc. Industrials 43.40 1.75x 99.5 95.6 $2.6B -$1.4M 51
3 RGLD Royal Gold, Inc. Basic Materials 218.09 1.69x 99.7 83.1 $14.3B 57
4 IMVT Immunovant, Inc. Healthcare 26.61 1.61x 100.0 80.0 $4.7B 51
5 PATK Patrick Industries, Inc. Consumer Cyclical 113.85 1.54x 98.1 75.0 $3.8B 51
6 ROIV Roivant Sciences Ltd. Healthcare 22.94 2.08x 100.0 65.0 $16.0B -$172.8M 55
7 AAL American Airlines Group Inc. Industrials 15.99 1.70x 100.0 60.0 $10.6B 37
8 FOLD Amicus Therapeutics, Inc. Healthcare 10.89 1.66x 100.0 58.8 $3.4B -$1.9M 64
9 TKO TKO Group Holdings, Inc. Communication Services 210.65 1.68x 100.0 50.6 $17.2B -$1.1M 71
10 ESTA Establishment Labs Holdings Inc. Healthcare 74.15 2.00x 100.0 46.2 $2.2B 71
11 EWBC East West Bancorp, Inc. Financial Services 114.47 1.61x 99.7 35.0 $15.7B -$2.6M 37
12 LAUR Laureate Education, Inc. Consumer Defensive 33.56 1.77x 100.0 33.8 $4.9B 65
13 HCC Warrior Met Coal, Inc. Basic Materials 83.55 1.52x 99.4 16.9 $4.4B -$1.6M 58
14 RRR Red Rock Resorts, Inc. Consumer Cyclical 62.67 1.64x 99.5 15.0 $3.7B 56
15 WTM White Mountains Insurance Group, Ltd. Financial Services 2045.31 1.70x 99.0 14.4 $5.2B 52
16 RBC RBC Bearings Incorporated Industrials 451.17 1.57x 97.6 13.8 $14.3B 45
17 AKRO Akero Therapeutics, Inc. Healthcare 54.65 2.22x 98.3 0.0 $4.5B -$1.7M 73

Field Notes

Understanding the Metrics:

  • Vol Thrust: Volume ratio vs 20-day average. AKRO's 2.22x means volume was 122% above normal—strong institutional activity.
  • % of 52-Week High: IMVT, ROIV, AAL, FOLD, TKO, ESTA, and LAUR are all making fresh 52-week highs today—classic breakout behavior.
  • Score: Composite quality metric (0-100). ENVA's 98.1 score is exceptional—strong momentum, relative strength, and technical setup.
  • Insider Net: ROIV stands out with -$172.8M in net insider selling—CEO and insiders have been liquidating heavily. This is a major red flag during a breakout. ENVA shows -$5.9M, also notable.
  • Days → Earnings: AAL and EWBC report in just 37 days (late January)—breakouts may be front-running earnings expectations.

Sector Observations:

  • Healthcare leads with 5 signals (IMVT, ROIV, FOLD, ESTA, AKRO)—strong biotech momentum continues
  • Industrials shows 3 signals (HUBG, AAL, RBC)—transportation and industrial recovery themes
  • Financial Services has 3 signals (ENVA, EWBC, WTM)—benefiting from stable rates and banking strength
  • Consumer Cyclical shows 2 signals (PATK, RRR)—RV manufacturing (PATK) and regional gaming (RRR)
  • Basic Materials has 2 signals (RGLD, HCC)—gold royalties and met coal

Market Context:

Monday, December 16, 2025 was a mixed session. The S&P 500 (^GSPC) finished nearly flat at 6800.25 (+0.002%), while the Nasdaq (^IXIC) climbed +0.56% to 23,111. Small caps stumbled—the Russell 2000 (^RUT) dropped -0.28%. The VIX fell -4.8% to 16.45, suggesting low volatility and complacent market conditions. Bitcoin rallied +1.6% to $87,832, while Ethereum slipped -0.3%.

This was a tech-led session with rotation into momentum names. The low VIX and positive Nasdaq suggest favorable conditions for momentum continuation strategies.


Recent Headlines

  • AAL — American Airlines: Multiple analysts offered rosy 2026 predictions; stock rallied +2.47% Friday. CEO unveiling new Airbus A321XLR with premium seat focus, targeting transcontinental/transatlantic routes. Exploring Amazon LEO satellite WiFi partnership.
  • RGLD — Royal Gold: Hit fresh 52-week high as gold prices remain elevated. Presented at Virtual Non-Deal Roadshow. Zacks highlighted strong Q3 results and recent acquisitions.
  • ROIV — Roivant Sciences: CEO sold $4.2M in stock Dec 9th; major insider Vivek Ramaswamy sold $100M+ since September. Investor Day Dec 11 highlighted pipeline progress and accelerated timelines for late-stage programs.
  • AKRO — Akero Therapeutics: Novo Nordisk completed $4.7B acquisition Dec 9th at $54/share plus CVR. All insiders liquidated positions (return transactions).
  • HUBG — Hub Group: President/CEO sold $1.4M shares Dec 11. Stock near 52-week high despite insider activity.
  • ENVA — Enova International: CEO sold shares in Sept/Oct; no recent news catalysts. Strong momentum despite insider sales.
  • FOLD — Amicus Therapeutics: Multiple insiders selling Nov-Dec; stock at 52-week high.
  • TKO — TKO Group Holdings: UFC/WWE parent company; Dwayne "The Rock" Johnson granted shares Nov 30; director Nick Khan selling regularly.
  • EWBC — East West Bancorp: CEO and COO both selling shares in Dec; approaching earnings Jan 22.

Vlad's Take (EverHint)

Market backdrop: S&P flat, Nasdaq +0.56%, Russell 2000 -0.28%. VIX at 16.45 (low volatility, complacent market). Bitcoin +1.6%, gold flat. This is a tech-led momentum environment with narrow leadership—exactly the type of market where mid-cap breakouts can work, but also where you need to be selective.

What I see: 15 of 17 signals are trading at or near 52-week highs—textbook breakout behavior. Volume is confirming institutional interest (average vol thrust 1.72x). But here's the concern: insider selling is widespread. ROIV's -$172.8M is egregious—insiders are using this momentum to exit. ENVA, HUBG, FOLD, EWBC, HCC all show net selling. Only RGLD, IMVT, PATK, AAL show clean insider data.

The playbook for mid-caps:

  1. Quality over quantity — Focus on top 5 scores (ENVA, HUBG, RGLD, IMVT, PATK). These have the cleanest setups.
  2. Watch the VIX — At 16.45, volatility is subdued. If VIX spikes above 20, tighten stops aggressively.
  3. Earnings proximity matters — AAL and EWBC report in 37 days. These could see pre-earnings positioning OR volatility into the print.
  4. Insider selling is a yellow flag, not a stop sign — Insiders sell for many reasons. But when ROIV insiders dump $173M during a breakout, that's not random. Proceed with caution.
  5. Tiered entries work best — Don't chase. Wait for pullbacks to 10-day MA or use limit orders 1-2% below current price.

Bottom line: This is a momentum-friendly environment, but insider activity suggests smart money is taking profits, not adding. Trade with defined stops, avoid overconcentration, and don't confuse a breakout with a buy-and-hold. Mid-caps can move fast—in both directions.

🔍 If this analysis helped you, a quick like, share, or subscribe supports the continued work behind EverHint.


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/